Index by author

February 01, 2000; Volume 67,Issue 2

  1. Roe, Matthew T.

    1. Glycoprotein Ilb/IIIa inhibitors in acute coronary syndromes
      Matthew T. Roe, MD, Shelly K. Sapp, MS and A. Michael Lincoff, MD
      Cleveland Clinic Journal of Medicine February 2000, 67 (2) 131-140;

      These potent antiplatelet agents constitute a breakthrough, hut questions remain about their safety, cost-effectiveness, and proper empiric use. With an illustration explaining the paradoxical prothrombotic effect of fibrinolytic drugs.

Back to top

In this issue